Thursday, 22 February 2018

Deal Making Gets Tougher for Generic Drugmakers

Generic drug M&A would seem logical, but a new policy at the FTC complicates matters.

from WSJ.com: Markets http://ift.tt/2HC3xzJ
via https://ifttt.com/ IFTTT
Posted by at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)